Overview

ED90 for Hyperbaric Bupivacaine in Super Obese Parturients

Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Treatments:
Bupivacaine